63 related articles for article (PubMed ID: 3942403)
1. Wrong tests, wrong conclusions.
Wilkerson MG; Wilkin JK
Arch Dermatol; 1986 Jan; 122(1):14-5. PubMed ID: 3942403
[No Abstract] [Full Text] [Related]
2. Motives and dinitrochlorobenzene.
Wilkin JK; Wilkerson MG
Arch Dermatol; 1986 Jan; 122(1):13-4. PubMed ID: 3942402
[No Abstract] [Full Text] [Related]
3. Potential hazards of dinitrochlorobenzene (DNCB) disputed.
Dunagin WG
Arch Dermatol; 1986 Jan; 122(1):11-3. PubMed ID: 3942401
[No Abstract] [Full Text] [Related]
4. [DNCB, a hazardous medication].
Bos RP; Brouns RM; Theuws JL; Henderson PT
Ned Tijdschr Geneeskd; 1980 May; 124(20):780-3. PubMed ID: 6991961
[No Abstract] [Full Text] [Related]
5. Adverse systemic reaction to dinitrochlorobenzene.
McDaniel DH; Blatchley DM; Welton WA
Arch Dermatol; 1982 Jun; 118(6):371. PubMed ID: 7092247
[No Abstract] [Full Text] [Related]
6. [Simulation of retarded allergic reaction in the nasal mucous membrane of guinea pigs].
Zabolotnyĭ DI
Zh Ushn Nos Gorl Bolezn; 1977; (3):59-64. PubMed ID: 878611
[No Abstract] [Full Text] [Related]
7. Contact urticaria to DNCB.
van Hecke E; Santosa S
Contact Dermatitis; 1985 May; 12(5):282. PubMed ID: 4028706
[No Abstract] [Full Text] [Related]
8. [Peroxidation of membrane lipids in experimental photochemotherapy].
Akimov VG; Lashmanva AP; Marzeeva GI
Vestn Dermatol Venerol; 1984 Aug; (8):22-5. PubMed ID: 6485534
[No Abstract] [Full Text] [Related]
9. DNCB, chemical laboratory workers, and chloramphenicol.
Pye RJ; Burton JL
Br Med J; 1976 Nov; 2(6044):1130-1. PubMed ID: 136288
[No Abstract] [Full Text] [Related]
10. Generalized urticaria from DNCB.
Valsecchi R; Foiadelli L; Reseghetti A; Cainelli T
Contact Dermatitis; 1986 Apr; 14(4):254-5. PubMed ID: 2941231
[No Abstract] [Full Text] [Related]
11. The role of mononitrochlorobenzene as a contaminant in dinitrochlorobenzene.
Doubleday CW; Wilkin JK
J Am Acad Dermatol; 1982 Mar; 6(3):325-7. PubMed ID: 7040504
[TBL] [Abstract][Full Text] [Related]
12. The potential hazards of dinitrochlorobenzene.
Happle R
Arch Dermatol; 1985 Mar; 121(3):330-2. PubMed ID: 3977355
[No Abstract] [Full Text] [Related]
13. Skin sensitization to 2, 4 dinitrochlorobenzene (DNCB) in the first months of life.
Cassimos C; Kanakoudi-Tsakalidis F; Spyroglou K; Ladianos M; Tzaphi R
J Clin Lab Immunol; 1980 Mar; 3(2):111-3. PubMed ID: 7205930
[TBL] [Abstract][Full Text] [Related]
14. [Dinitrochlorobenzene. Therapeutic use].
Heid E; Grosshans E; Laplanche G; Caussade P
Ann Dermatol Venereol; 1984; 111(9):841-9. PubMed ID: 6393839
[No Abstract] [Full Text] [Related]
15. [Dinitrochlorobenzene treatment of alopecia areata].
de Groot AC; Nater JP; de Jong MC
Ned Tijdschr Geneeskd; 1980 Sep; 124(39):1634-40. PubMed ID: 7412951
[No Abstract] [Full Text] [Related]
16. An evaluation of the sensitivity of the Ames assay to discern low-level mutagenic impurities.
Kenyon MO; Cheung JR; Dobo KL; Ku WW
Regul Toxicol Pharmacol; 2007 Jun; 48(1):75-86. PubMed ID: 17379368
[TBL] [Abstract][Full Text] [Related]
17. Development of sensitivity oto dinitrochlorobenzene in patients with sarcoidosis.
Jones JV
Clin Exp Immunol; 1967 Jul; 2(4):477-87. PubMed ID: 6052543
[TBL] [Abstract][Full Text] [Related]
18. Topical treatment of alopecia areata.
Swanson NA; Mitchell AJ; Leahy MS; Headington JT; Diaz LA
Arch Dermatol; 1981 Jul; 117(7):384-7. PubMed ID: 7259216
[TBL] [Abstract][Full Text] [Related]
19. Spy dust: science or politics?
Rosenkranz HS
Mutat Res; 1986 Feb; 164(1):1-2. PubMed ID: 3951460
[No Abstract] [Full Text] [Related]
20. Dinitrochlorobenzene: influence on the cytochrome P-450 system and mutagenic effects.
Kratka J; Goerz G; Vizethum W; Strobel R
Arch Dermatol Res; 1979 Nov; 266(3):315-318. PubMed ID: 526052
[No Abstract] [Full Text] [Related]
[Next] [New Search]
